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Dear Sirs,
The authors Abbas SM, and Hill AG [1] outline their expe-
rience of a case of prostatic sarcoma occurring four years
post neoadjuvant radiation therapy for primary mid rectal
adenocarcinoma. They correctly state that as this second
malignancy occurred within the radiation field it meets
the criteria for a radiation – induced second malignancy.
However, it has been noted that while there is no estab-
lished dose response relationship for sarcoma that they
are generally felt to occur within the high dose region. A
dose of 4500 cGy seems unlikely to lead to sarcoma for-
mation within such a short time frame.
While post radiation sarcomas have commonly been
described in the pelvis they more commonly follow high
dose 3 Dimensional Conformal Radiation therapy
(3DCRT) with or without intracavitary brachytherapy
(doses > 7000 cGy) in gynecological cancers, or in combi-
nation with interstitial seed brachytherapy (doses > 1000
cGy) in prostatic malignancy. In contrast, primary pros-
tatic sarcoma is a well recognized clinical entity with over
50 cases recorded in the literature [2-4].
While the author's assertion that this is a radiation
induced second malignancy is supported by the temporal
association, radiobiologically it is not. However, this case
is a salient reminder of the significant risks associated with
all forms of cancer therapy.
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